AI assistant
Sending…
AGENUS INC — Director's Dealing 2016
Mar 8, 2016
34023_dirs_2016-03-08_4e4aaff6-98d0-4dfb-959f-6fe3af07a2a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2016-03-07
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-07 | Common Stock | P | 200000 | $4.028 | Acquired | 1251228 | Direct |
Footnotes
F1: Dr. Armen's purchase of Agenus Inc. common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with Dr. Armen's sale of an equivalent number of shares of Agenus common stock at a weighted average price of $4.5919 per share on December 28 and December 29, 2015. Dr. Armen has paid to Agenus, as of March 8, 2016, $96,035.81, representing the full amount of the profit realized in connection with the short-swing transaction.
More from AGENUS INC
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Legal Proceedings Report
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23